References
- Bielenberg DR, Zetter BR. The Contribution of angiogenesis to the process of metastasis. Cancer J 2015;21:267-73. https://doi.org/10.1097/PPO.0000000000000138
- Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag 2006;2:213-9. https://doi.org/10.2147/vhrm.2006.2.3.213
- Brooks PC. Role of integrins in angiogenesis. Eur J Cancer 1996;32:2423-9. https://doi.org/10.1016/S0959-8049(96)00381-4
- Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004;90:561-5. https://doi.org/10.1038/sj.bjc.6601576
- Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996;8:724-30. https://doi.org/10.1016/S0955-0674(96)80115-3
- Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100. https://doi.org/10.1038/nrc727
-
Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin
${\alpha}_{v}{\beta}_{3}$ for angiogenesis. Science 1994;264:569-71. https://doi.org/10.1126/science.7512751 - Choe YS, Lee KH. Targeted in vivo imaging of angiogenesis: present status and perspectives. Curr Pharm Design 2007;13:17-31. https://doi.org/10.2174/138161207779313812
-
Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stocklin G, Schwaiger M. Raiolabeled
${\alpha}_{v}{\beta}_{3}$ integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999;40:1061-71. -
Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R, Kessler H, Schwaiger M. Noninvasive imaging of
${\alpha}_{v}{\beta}_{3}$ integrin expression using$^{18}F$ -labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001; 61:1781-5. -
Jung KH, Lee KH, Paik JY, Ko BH, Bae JS, Lee BC, Sung HJ, Kim DH, Choe YS, Chi DY. Favorable biokinetic and tumor-targeting properties of
$^{99m}Tc$ -labeled glucosamino RGD and effect of Paclitaxel therapy. J Nucl Med 2006;47:2000-7. -
Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa SA, Davis PJ. Integrin
${\alpha}_{v}{\beta}_{3}$ contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005;146:2864-71. https://doi.org/10.1210/en.2005-0102 - Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis 2008;11:183-90. https://doi.org/10.1007/s10456-007-9088-7
-
Kang CM, Koo HJ, Lee S, Lee KC, Oh YK, Choe YS.
$^{64}Cu$ -Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis. Nucl Med Biol 2013;40:1018-24. https://doi.org/10.1016/j.nucmedbio.2013.08.003 -
Kim H, Koo HJ, Ahn J, Kim JY, Choi JY, Lee KH, Kim BT, Choe YS. Synthesis and characterization of
$^{64}Cu$ and Cy5.5-labeled tetraiodothyroacetic acid derivatives for tumor angiogenesis imaging. Bioorg Med Chem 2020;28:115212. https://doi.org/10.1016/j.bmc.2019.115212 - Nunez R, Erwin WD, Wendt RE 3rd, Stachowiak A, Mar M, Stevens D, Madewell JE, Yeung HW, Macapinlac HA. Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner. Mol Imaging Biol 2010;12:110-38. https://doi.org/10.1007/s11307-009-0266-4
- Saha GB. Fundamentals of nuclear pharmacy. 5th ed. New York: Springer; 2004. p. 97.
- Choe YS. Radiolabeling methods used for preparation of molecular probes. Korean J Nucl Med 2004;38:121-30.
-
Leamon CP, Parker MA, Vlahov IR, Xu LC, Reddy JA, Vetzel M, Douglas N. Synthesis and biological evaluation of EC20: a new folate-derived,
$^{99m}Tc$ -based radiopharmaceutical. Bioconjugate Chem 2002;13:1200-10. https://doi.org/10.1021/bc0200430 -
Kim MH, Kim WH, Kim CG, Kim DW. Synthesis and evaluation of
$^{99m}Tc$ -labeled folate-tripeptide conjugate as a folate receptor-targeted imaging agent in a tumor-bearing mouse model. Nucl Med Mol Imaging 2015;49:200-7. https://doi.org/10.1007/s13139-015-0336-2 - Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev 2008;60:1347-70. https://doi.org/10.1016/j.addr.2008.04.006
- Saha GB. Fundamentals of nuclear pharmacy. 5th ed. New York: Springer; 2004. p. 111.
-
Turaga RC, Yin L, Yang JJ, Lee H, Lvanov L, Yan C, Yang H, Grossniklaus HE, Wang S, Ma C, Sun L, Liu ZR. Rational design of a protein that binds integrin
${\alpha}_{v}{\beta}_{3}$ outside the ligand binding site. Nat Commun 2016;31:11675. -
Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X. Quantitative PET imaging of tumor integrin
${\alpha}_{v}{\beta}_{3}$ expression with$^{18}F$ -FRGD2. J Nucl Med 2006;47:113-21